Novel substituted 4-(1H-benzimidazol-2-yl) [1,4]diazepanes useful for the treatment of allergic diseases
AssigneeAventis Pharmaceuticals Inc.
InventorsGeorge D. Maynard, Tieu-Binh Le
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula 1 and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
Claims27
A compound, including enantiomers, stereoisomers, rotomers and tautomers of said compound and pharmaceutically acceptable salts, solvates or derivatives thereof, with said compound having the general structure shown in the formula:
- 153
- wherein
- m is 2 or 3;
- A is 1 or 2;
- G is —C(O)—, —C(O)—CH2—, or —SO2—;
- R30 is selected from the group consisting of:
- —C5-C8 alkyl, —(CH2)pCF3, vinyl,
- 154
- wherein
- p is an integer from 1 to 4;
- B is an integer from 1 to 4;
- D is an integer from 1 to 4;
- s is an integer from 1 to 4;
- and
- R34 is C1-C4 alkyl;
- R3, and R32 are the same or different and are independently selected from hydrogen or C1-C4 alkoxy;
- and
- R33 is selected from the group consisting of:
- hydrogen, C1-C4 alkoxy,
- 155
- wherein
- E is an integer from 2 to 4.
Dependencies are inferred from the claim text.